LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice

Amena Archer, Emilie Stolarczyk, Maria Luisa Doria, Luisa Helguero, Rosario Domingues, Jane K Howard, Agneta Mode, Marion Korach Andre, Jan-Ake Gustafsson

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

To investigate the role of LXR in adipose tissue metabolism during obesity, ob/ob mice were treated for 5 weeks with the synthetic LXR agonist GW3965. MRI analysis revealed that pharmacological activation of LXR modified fat distribution by decreasing visceral (VS) fat and inversely increasing subcutaneous (SC) fat storage without affecting whole body fat content. This was concordant with opposite regulation by GW3965 of the lipolytic markers HSL and ATGL in the two fat depots; moreover the expression of genes involved in lipogenesis was significantly induced in SC fat. Lipidomic analysis suggested that changes in lipid composition in response to GW3965 also varied between VS and SC fat. In both depots the observed alteration in lipid composition indicated an overall change towards less lipotoxic lipids. Flow cytometry analysis showed decreased immune cell infiltration in adipose tissue of ob/ob mice in response to GW3965 treatment, which in VS fat mainly affected the macrophage population and in SC fat the lymphocyte population. In line with this, the expression and secretion of pro-inflammatory markers was decreased in both fat deposits with GW3965 treatment.
Original languageEnglish
Pages (from-to)1300-1311
Number of pages12
JournalJournal of Lipid Research
Volume54
DOIs
Publication statusPublished - 27 Feb 2013

Fingerprint

Dive into the research topics of 'LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice'. Together they form a unique fingerprint.

Cite this